Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study.
Researchers at the University of Chicago have successfully captured detailed images of adhesion G protein-coupled receptors, ...
The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...
Finding similar frequencies of positive acetylcholine receptor antibodies in patients with ocular and generalized myasthenia ...
In 1991, Strader and colleagues conducted foundational work that paved the way for chemogenetics by altering the β-adrenergic receptor, which belongs to a family known as G-protein-coupled receptors ...
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in ...
Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited ...
Paxneury and Tuzulby should be granted Europe-wide marketing authorizations for treating attention-deficit hyperactivity, the ...
15d
MEDICATIONS taken by thousands of Brits for to treat an overactive bladder have been linked to dementia in a new study. Some forms of the medication have been found to raise the risk of dementia ...
About Rapiblyck TM (landiolol) intravenous [280 mg of landiolol (equivalent to 300 mg of landiolol HCl) in a single-dose vial] Landiolol is an ultra-short-acting adrenergic receptor antagonist, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback